Health score, price, valuation, risk signals, and key metrics at a glance.
Strongest: Growth (16.5/25); weakest: Cash & Earnings Quality (2/25).
Data-driven signals worth keeping an eye on across the last 8 quarters
Operating margins declined 9.1% — watch for continued compression, which may signal competitive or cost pressure.
Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.
as of May 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
D/E ratio of 2.1 is elevated. Watch for further debt accumulation.
The last 8 consecutive quarters had negative FCF — the company is burning cash and may need external funding.